In Annals of Oncology, the ESMO - Eur. Oncology Clinical Practice Guideline interim update on 1st-line therapy in advanced urothelial carcinoma following the results of the EV-302/KEYNOTE-A39 randomized phase 3 trial initially presented by Tom Powles at #ESMO23
annalsofoncology.org/article/S0923-…

Congrats Tom Powles and team #EVP for establishing the new SOC in advanced bladder cancer NEJM —this is a transformative trial for our patients.

Mohamed Osman splernerMD Sia Daneshmand, M.D. Thomas Flaig David McConkey Matt Milowsky Dan Theodorescu Petros Grivas Sumanta K. Pal, MD, FASCO Bladder Cancer Bladder Cancer OncoAlert WCM Englander Institute for Precision Medicine Weill Cornell Medicine The ASCO Post OncLive.com Scott Tagawa David M. Nanus Cora Sternberg Dr. Jones Nauseef Ashish M. Kamat, MD, MBBS Neeraj Agarwal, MD, FASCO Join us in this session with highly anticipated results of EV302 subgroup analysis, PemCab, AMBASSADOR clinical trials and our AI work to predict outcomes from SWOG1314 OncoAlert UroToday.com @ASCO #GU24

We covered the issue of equity, then ‘we are doing something’ examples and ‘policies are hindering innovation’ rhetoric on the panel. We know this is the state right now, but surely as a society we must expect the #pharmaceutical industry to do MUCH better in equitable access to…

The #ESMO23 Highlight videos series - daily interviews with selected LBA presenters.🔗ow.ly/xJ6250Q1rSA
With Laurence Albiges, Yelena Y. Janjigian MD, Ben Solomon, Herbert Loong, Michiel van der Heijden, Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ, Domenica Lorusso, Julien Hadoux, Filippo Pietrantonio, Funda Meric-Bernstam, Aaron…

Dear friends, #ESMO23 has been truly amazing, inspiring & most of all bringing better treatments to patients. Closing off was the amazing Greek wolverine, chief question officer Petros Grivas and chair of the best ESMO ever silke gillessen !! Toni Choueiri, MD Ignacio Duran

I’m hoping people applaud at the end of this podcast as after Tom Powles presentation.

Yesterday at #ESMO23 we witnessed history:

✅EV/P & N/GC improved survival for pts w/ mUC for the 1st time since the 1990s!

A standing ovation for all pts and investigators who got us to this point💫

Tom Powles Michiel van der Heijden
ESMO - Eur. Oncology OncoAlert

CheckMate 901 folks #ESMO23 Bladder Cancer Advocacy Network The Tisch Cancer Institute Guru P. Sonpavde, MD Michiel van der Heijden Yüksel Ürün
nejm.org/doi/full/10.10…

There is really important biology hiding in plain sight in IMvigor130, KN361, CM901, and EV302. This provides some direction on how to move forward. Lets celebrate the wins & think carefully about the future. Uromigos Michiel van der Heijden Tom Powles Jonathan Rosenberg MD Petros Grivas

Midway update nonprostate GU track, very exciting #ESMO23 !! ESMO - Eur. Oncology Petros Grivas Tom Powles Andrea Apolo, M.D. Andrea Necchi Christian Blank Toni Choueiri, MD Laurence Albiges Christian Blank Matt Galsky

Congrats to Dr. Sarah Einerhand Michiel van der Heijden for an investigator initiated trial showing promising ORR with paclitaxel + high dose treme, worthy of further investigation! Excellent discussion by Tom Powles Uromigos ESMO - Eur. Oncology OncoAlert silke gillessen Guru P. Sonpavde, MD Tian Zhang, MD, MHS